Healthequity (HQY) Net Cash Flow (2013 - 2026)

Healthequity has reported Net Cash Flow for 14 years, with the latest figure at -$9.4 million in Q3 2026.

• On a quarterly basis, Net Cash Flow fell 156.53% year-over-year to -$9.4 million in Q3 2026; TTM through Jul 2026 was -$48.5 million, a 116.02% decrease from a year earlier, with the FY2026 full-year figure at $23.0 million, up 121.27% from the prior year.
• Net Cash Flow was -$9.4 million for Q3 2026 at Healthequity, up from -$53.6 million in the prior quarter.
• The five-year high for Net Cash Flow was $75.7 million in Q3 2024, with the low at -$423.7 million in Q1 2022.
• Average Net Cash Flow over 5 years is -$20.7 million, with a median of $4.8 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Net Cash Flow slumped 1538.91% in 2022, then surged 313.73% in 2023.
• Over 5 years, Net Cash Flow stood at $33.3 million in 2022, then surged by 31.24% to $43.7 million in 2023, then sank by 110.82% to -$4.7 million in 2024, then surged by 201.44% to $4.8 million in 2025, then plunged by 295.21% to -$9.4 million in 2026.
• The last three Net Cash Flow figures came in at -$9.4 million (Q3 2026), -$53.6 million (Q2 2026), and $9.7 million (Q1 2026), per Business Quant data.